Home › Paraganglioma › Pennsylvania
Paraganglioma clinical trials in Pennsylvania
3 studies for Paraganglioma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
- PENN, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07282587Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- Penn Medicine, Philadelphia
Recruiting
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT06377033In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT05636540From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.